UBS Group AG - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 111 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2015. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$19,000
-96.9%
2,100
-98.1%
0.00%
Q2 2016$607,000
-35.3%
113,018
-44.6%
0.00%
Q1 2016$938,000
-20.5%
204,059
-10.1%
0.00%
Q4 2015$1,180,000
+122.2%
226,940
+158.4%
0.00%
Q3 2015$531,000
-22.5%
87,829
+102.5%
0.00%
Q2 2015$685,000
-19.0%
43,368
-44.3%
0.00%
-100.0%
Q1 2015$846,000
+1333.9%
77,900
+1307.4%
0.00%
Q4 2014$59,0005,5350.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders